In vitro activity of Eravacycline against carbapenem-resistant gram-negative bacilli and associated risk factors for non-susceptible infections from a tertiary hospital in fujian, China from 2021 to 2024
Our study demonstrated that ERV effectively combats CRGNB, providing a potential basis for future treatment of drug-resistant infections. ENSKP infection can occur without ERV use. Effective surveillance and antibiotic stewardship are essential for managing ENSKP in high-risk patients.
Authors
- Xiaohong Xu (ORCID: https://orcid.org/0000-0001-7986-0115)
- Bin Li (ORCID: https://orcid.org/0000-0002-3360-7250)
- Xuyang Li (ORCID: https://orcid.org/0009-0007-2405-9890)
- Meiyun Chen (ORCID: https://orcid.org/0000-0002-3129-5978)
- Pengfei Gao (ORCID: https://orcid.org/0000-0002-2057-4058)
Institutions
- Fujian Medical University (CN)
- Fuzhou Second Hospital (CN)
- Union Hospital (CN)
- Putian University (CN)
Publication Details
- Journal
- BMC Microbiology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1186/s12866-025-04331-7
- Citations
- 2
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.18
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Commission